1 / 8

Aspirin for Pre-eclampsia?

Aspirin for Pre-eclampsia?. Max Brinsmead MB BS PhD July 2015. Resource for this Presentation:. Cochrane Database “Anti platelet agents for preventing pre –eclampsia and its complications” A Review published February 2007 And its conclusions confirmed in 2010. Hypothesis.

shammons
Download Presentation

Aspirin for Pre-eclampsia?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Aspirin for Pre-eclampsia? Max Brinsmead MB BS PhD July 2015

  2. Resource for this Presentation: • Cochrane Database • “Anti platelet agents for preventing pre –eclampsia and its complications” • A Review published February 2007 • And its conclusions confirmed in 2010

  3. Hypothesis • Pre-eclampsia is associated with: • ↓Intravascular Prostacyclin • A vasodilator • And... • ↑Production of Thromboxane • That increases platelet stickiness • So low dose aspirin may prevent or reduce the severity of this disease

  4. A Meta analysis of 59 trials involving 37,560 women found that Aspirin will • Reduce the risk of pre-eclampsia by 17% • (RR 0.83 and CI 0.77 – 0.89) • Number needed to treat is 72 • But for high risk patients the number needed to treat is 19 • When high risk is defined as: • Previous severe pre-eclampsia • Chronic hypertension • Diabetes • Renal disease • Auto immune disease

  5. Other Outcomes • Reduce the risk of preterm delivery by 8% • (RR 0.92 CI 0.88 – 0.97) • Reduce the risk of perinatal death by 14% • (RR 0.86 CI 0.76 – 0.98) • Reduce the rate of SGA infants by 10% • (RR 0.90 CI 0.83 – 0.98) • No significant effect on: • Risk of maternal death • Rate of Caesarean • Induction of Labour • Antenatal admission or Nursery Use

  6. Is it Safe? • The rate of abruptio placenta is increased by 10% but this difference is not significant • (RR 1.10 CI 0.89-1.37) • No increased rate of Neonatal Intracerebral Haemorrhage • Or any measure of neonatal bleeding • One study (CLASP,1994) followed children to 18 months of age and found no observable differences • Another study (Italy, 1993) found higher rates of gross and fine motor problems in children of treated mothers at 18 months but this study was unblinded and had other follow problems

  7. Unanswered Questions • What is the best dose? • 75 mg daily is safe • Some evidence that higher doses may be more effective • When should the Aspirin be started? • This study showed no difference in outcomes when analysed according to commencement before or after 20 weeks gestation • But many argue that most benefit is likely to occur with commencement at <12 weeks and before trophoblast invasion of spiral arterioles occurs • Are adjuvants likley to be useful? e.g. • Other anti-platelet agents or even Heparin • Ca or Mg • Fish oil • (antioxidants have been ruled out)

  8. Any Questions or Comments? Please leave a note on the Welcome Page to this website

More Related